Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTA2,"Actin, aortic smooth muscle",22843,165,1.51 [1.19-1.93],0.0007563836814616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACVRL1,Serine/threonine-protein kinase receptor R3,23021,168,2.85 [1.84-4.42],2.954716898337917e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA2,Adenosine deaminase 2,23148,170,1.75 [1.32-2.32],0.0001047034246439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE1,Adhesion G protein-coupled receptor E1,20100,129,1.64 [1.24-2.19],0.0006066246971014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRN,Agrin,23346,169,1.77 [1.28-2.44],0.0005311400263395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBP,Protein AMBP,23430,170,3.45 [1.84-6.47],0.000112472552169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMFR,E3 ubiquitin-protein ligase AMFR,22749,164,1.40 [1.18-1.66],0.0001139823940779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AREG,Amphiregulin,23153,167,2.17 [1.64-2.88],5.994672424983498e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARG1,Arginase-1,23102,167,0.64 [0.49-0.83],0.0008758340244771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR1,Asialoglycoprotein receptor 1,23062,169,1.98 [1.33-2.93],0.0007184784730036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GALT1,"Beta-1,4-galactosyltransferase 1",23346,169,2.62 [1.67-4.10],2.7152300848659783e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAMBI,BMP and activin membrane-bound inhibitor homolog,22716,165,2.25 [1.57-3.24],1.1075089622638234e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST2,Bone marrow stromal antigen 2,23472,168,1.66 [1.36-2.03],5.326395565016365e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN2A1,Butyrophilin subfamily 2 member A1,23346,169,2.37 [1.55-3.63],7.155068455698005e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN3A2,Butyrophilin subfamily 3 member A2,23240,169,1.75 [1.34-2.29],3.993054102611174e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA12,Carbonic anhydrase 12,23153,167,1.89 [1.32-2.70],0.0004758466731363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA6,Carbonic anhydrase 6,23206,167,0.66 [0.54-0.82],0.0001612043357851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALB2,Calretinin,22749,164,1.61 [1.26-2.07],0.0001846241816621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPN3,Calpain-3,20093,131,1.76 [1.36-2.27],1.662724677638154e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC80,Coiled-coil domain-containing protein 80,23267,170,1.92 [1.37-2.70],0.0001454392998509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL21,C-C motif chemokine 21,23346,169,1.60 [1.23-2.07],0.00044261656712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL22,C-C motif chemokine 22,22998,168,1.49 [1.18-1.89],0.0008292571974738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN3,CCN family member 3,23514,171,2.11 [1.51-2.96],1.3194569699437943e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD163,Scavenger receptor cysteine-rich type 1 protein M130,23375,171,1.79 [1.34-2.38],6.703210822472128e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD244,Natural killer cell receptor 2B4,23536,169,2.32 [1.47-3.64],0.0002682828470815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD27,CD27 antigen,23327,169,2.03 [1.55-2.65],2.2119058538031617e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD274,Programmed cell death 1 ligand 1,23062,169,1.78 [1.27-2.51],0.0009005264178025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD28,T-cell-specific surface glycoprotein CD28,22716,165,1.75 [1.35-2.28],2.576263987516985e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300C,CMRF35-like molecule 6,23472,168,2.12 [1.48-3.02],3.7673326222043184e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300E,CMRF35-like molecule 2,23403,170,2.33 [1.77-3.07],1.646576142048426e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD4,T-cell surface glycoprotein CD4,23204,169,2.11 [1.56-2.86],1.354293330953632e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD48,CD48 antigen,23310,169,2.84 [1.91-4.22],2.288570668727927e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD74,HLA class II histocompatibility antigen gamma chain,23472,168,2.41 [1.70-3.43],8.81559267025965e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD80,T-lymphocyte activation antigen CD80,20163,130,2.56 [1.73-3.79],2.642538453829466e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD83,CD83 antigen,23240,169,2.11 [1.49-2.98],2.598272188066976e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDCP1,CUB domain-containing protein 1,23062,169,1.54 [1.25-1.90],5.980086624331398e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL1,Chordin-like protein 1,23310,169,2.71 [1.83-4.01],5.867307572295314e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKAP4,Cytoskeleton-associated protein 4,23424,168,1.96 [1.34-2.85],0.0004949849221521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC6A,C-type lectin domain family 6 member A,22716,165,1.59 [1.22-2.08],0.0006590937589923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC7A,C-type lectin domain family 7 member A,23536,169,1.87 [1.40-2.49],1.923315407277199e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL18A1,Collagen alpha-1(XVIII) chain,23370,171,3.42 [2.00-5.86],7.736710346642303e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL28A1,Collagen alpha-1(XXVIII) chain,19624,123,0.67 [0.53-0.85],0.0009219800460389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL6A3,Collagen alpha-3(VI) chain,23559,171,2.39 [1.76-3.24],1.9972452086261842e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COLEC12,Collectin-12,23227,169,2.86 [1.85-4.41],2.011684089822373e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIP2,Cysteine-rich protein 2,23062,169,1.70 [1.32-2.18],3.978220612053142e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAM,Cytotoxic and regulatory T-cell molecule,23062,169,1.63 [1.26-2.11],0.0002196889561003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB2,Beta-crystallin B2,20115,129,1.49 [1.32-1.67],2.422530133087745e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1,Macrophage colony-stimulating factor 1,23346,169,2.54 [1.60-4.04],7.483262031524862e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1R,Macrophage colony-stimulating factor 1 receptor,20188,130,2.05 [1.47-2.87],2.4444530472486923e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST3,Cystatin-C,23331,171,2.55 [1.72-3.76],2.697958985692866e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXADR,Coxsackievirus and adenovirus receptor,23240,169,1.64 [1.28-2.09],7.046860136885474e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL9,C-X-C motif chemokine 9,23346,169,1.40 [1.18-1.67],0.0001741169530423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSC2,Desmocollin-2,22999,166,2.39 [1.68-3.40],1.2637850805826297e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDA2R,Tumor necrosis factor receptor superfamily member 27,23465,170,1.99 [1.47-2.69],7.847386832331187e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,23340,171,2.05 [1.38-3.04],0.0003854742202418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA1,Ephrin-A1,23236,167,2.80 [1.92-4.08],8.757257207257973e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA4,Ephrin-A4,23021,168,2.81 [2.06-3.84],5.879179887151136e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA2,Ephrin type-A receptor 2,22399,163,2.48 [1.74-3.53],4.624437497399186e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB4,Ephrin type-B receptor 4,23559,171,2.75 [1.75-4.33],1.2362099837777832e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP1,"Fatty acid-binding protein, liver",23227,169,1.31 [1.15-1.49],6.034560223832808e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP4,"Fatty acid-binding protein, adipocyte",23559,171,1.64 [1.30-2.08],4.0267191717085e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3C,Protein FAM3C,23237,170,2.33 [1.55-3.49],4.213703144287042e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF23,Fibroblast growth factor 23,23424,170,1.41 [1.16-1.71],0.0006169046748021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF5,Fibroblast growth factor 5,22853,166,1.92 [1.35-2.72],0.0002811698835708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGL1,Fibrinogen-like protein 1,20188,130,1.55 [1.22-1.97],0.0003902812987048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,23062,169,2.61 [1.71-4.01],1.0313286182663965e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR2,Folate receptor beta,23472,168,2.25 [1.44-3.49],0.000334123743199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL3,Follistatin-related protein 3,23195,168,2.43 [1.71-3.45],8.030196214941276e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP4,Guanylate-binding protein 4,22749,164,1.63 [1.30-2.03],1.842942873438216e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",23153,167,2.00 [1.37-2.92],0.0003442326137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF15,Growth/differentiation factor 15,23559,171,2.06 [1.66-2.55],3.738353260766097e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA1,GDNF family receptor alpha-1,23439,170,2.70 [1.78-4.08],2.7186686077163032e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHR,Growth hormone receptor,19710,123,0.32 [0.17-0.58],0.0001984643188078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPNMB,Transmembrane glycoprotein NMB,22637,166,2.27 [1.42-3.62],0.0005716757226894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR37,Prosaposin receptor GPR37,22843,165,1.55 [1.26-1.91],3.4700779028227435e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCA2A,Guanylin,23157,166,2.12 [1.50-2.99],1.8929595204347463e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR1,Hepatitis A virus cellular receptor 1,23430,170,1.41 [1.17-1.71],0.0003093263280965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR2,Hepatitis A virus cellular receptor 2,23278,167,2.56 [1.86-3.51],6.032612928261888e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",23163,169,1.80 [1.27-2.53],0.0008620873213958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-E,"HLA class I histocompatibility antigen, alpha chain E",23240,169,2.15 [1.45-3.20],0.0001368540711293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNMT,Histamine N-methyltransferase,22958,168,1.63 [1.24-2.13],0.0003970884588863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPB6,Heat shock protein beta-6,23465,170,1.70 [1.26-2.30],0.0005747019197115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,23112,170,2.18 [1.45-3.29],0.0001986320259975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM3,Intercellular adhesion molecule 3,23559,171,2.17 [1.38-3.43],0.0008609514856038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDI2,Isopentenyl-diphosphate delta-isomerase 2,22749,164,1.54 [1.21-1.96],0.0004562404806663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR1,Interferon gamma receptor 1,23346,169,2.35 [1.49-3.71],0.000237666416502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP2,Insulin-like growth factor-binding protein 2,23524,171,1.48 [1.19-1.84],0.0005168871218302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP4,Insulin-like growth factor-binding protein 4,23002,166,1.69 [1.31-2.17],4.632105413442875e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10RB,Interleukin-10 receptor subunit beta,23346,169,2.33 [1.68-3.21],3.0057406466293496e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12RB1,Interleukin-12 receptor subunit beta-1,22853,166,1.85 [1.30-2.62],0.0005927711412801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15RA,Interleukin-15 receptor subunit alpha,22853,166,2.04 [1.39-2.99],0.0002523819269409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17C,Interleukin-17C,22853,166,1.42 [1.22-1.65],5.912140290248685e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18,Interleukin-18,23148,169,1.66 [1.26-2.18],0.0003586310424435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18BP,Interleukin-18-binding protein,23375,171,2.18 [1.49-3.19],6.44093577393186e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL19,Interleukin-19,22688,168,1.36 [1.16-1.59],0.0001162980667965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22,Interleukin-22,20093,131,1.44 [1.18-1.77],0.0004406737966397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RA,Interleukin-2 receptor subunit alpha,23121,166,1.89 [1.46-2.46],1.5826071831957688e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4R,Interleukin-4 receptor subunit alpha,23240,169,1.79 [1.29-2.49],0.0005240517394174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,23375,171,1.87 [1.31-2.67],0.0005427329754771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK11,Kallikrein-11,23108,169,1.79 [1.35-2.36],4.125597484749375e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK4,Kallikrein-4,23465,170,1.54 [1.30-1.83],6.097964113655998e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRB1,Killer cell lectin-like receptor subfamily B member 1,23536,169,2.04 [1.48-2.81],1.274288969626044e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,23227,169,1.95 [1.54-2.48],3.374034421575212e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAYN,Layilin,23029,169,2.21 [1.61-3.03],7.856843256607303e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS4,Galectin-4,23227,169,1.61 [1.29-1.99],1.739695403835178e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS9,Galectin-9,23235,169,2.83 [1.93-4.14],9.493524507955972e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,23278,167,1.99 [1.33-2.97],0.0007791370871187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,23237,170,2.04 [1.36-3.05],0.0005445115925879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22853,166,1.99 [1.50-2.64],1.72428635704682e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBR,Tumor necrosis factor receptor superfamily member 3,23107,169,2.31 [1.56-3.41],2.782543755139289e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY6D,Lymphocyte antigen 6D,23115,168,1.70 [1.28-2.26],0.0002285300097576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY96,Lymphocyte antigen 96,23062,169,1.85 [1.36-2.52],8.7888907828869e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN2,Matrilin-2,23263,169,2.40 [1.54-3.74],0.0001151288298353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP12,Macrophage metalloelastase,23297,169,1.60 [1.27-2.01],5.191289150938502e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRC1,Macrophage mannose receptor 1,20188,130,3.28 [1.92-5.60],1.3798950485630453e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSR1,Macrophage scavenger receptor types I and II,23472,168,1.74 [1.32-2.31],0.0001049454733288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBL1,Neuroblastoma suppressor of tumorigenicity 1,23327,169,2.28 [1.44-3.61],0.000447138325805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN2,Nectin-2,23237,170,2.03 [1.37-3.01],0.0003951442789545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEFL,Neurofilament light polypeptide,22681,163,1.88 [1.52-2.32],4.732691516886663e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS1,"Nitric oxide synthase, brain",22749,164,1.49 [1.21-1.83],0.0001747975929649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPDC1,Neural proliferation differentiation and control protein 1,23267,170,2.08 [1.53-2.82],3.094252770702082e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OCLN,Occludin,20124,129,1.77 [1.27-2.46],0.0006820638448326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGN,Mimecan,23278,167,2.05 [1.55-2.70],4.67801868420571e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSCAR,Osteoclast-associated immunoglobulin-like receptor,23263,169,2.02 [1.37-3.00],0.0004115482946575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGF,Placenta growth factor,23536,169,2.31 [1.58-3.39],1.7574431564210998e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PI3,Elafin,22970,167,1.43 [1.16-1.77],0.0007367120670389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIGR,Polymeric immunoglobulin receptor,22974,165,1.89 [1.34-2.66],0.0002514107884162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,23278,167,2.37 [1.61-3.48],1.1650600489663616e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRA,Paired immunoglobulin-like type 2 receptor alpha,23278,167,2.16 [1.57-2.97],2.335193028448871e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRB,Paired immunoglobulin-like type 2 receptor beta,23267,170,1.75 [1.35-2.26],2.0638735017746687e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAUR,Urokinase plasminogen activator surface receptor,23073,169,3.12 [2.06-4.73],8.110007976142903e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB2,Plexin-B2,23445,171,2.38 [1.45-3.92],0.0006585916189157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PREB,Prolactin regulatory element-binding protein,22853,166,1.89 [1.33-2.69],0.0003597800811023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGDS,Prostaglandin-H2 D-isomerase,23112,170,2.06 [1.46-2.92],4.54123020338046e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBFOX3,RNA binding protein fox-1 homolog 3,20124,129,1.76 [1.31-2.38],0.0002096324431473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1A,Lithostathine-1-alpha,23148,170,1.59 [1.27-1.99],4.951340887577055e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1B,Lithostathine-1-beta,23559,171,1.47 [1.20-1.79],0.0001540759995651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3A,Regenerating islet-derived protein 3-alpha,23559,171,1.46 [1.22-1.76],5.374153362737629e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG4,Regenerating islet-derived protein 4,23263,169,1.67 [1.31-2.12],2.9494028165155933e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELT,Tumor necrosis factor receptor superfamily member 19L,23278,167,2.27 [1.53-3.37],4.259587895693196e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REN,Renin,23267,170,1.34 [1.16-1.54],5.382897962931476e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE6,Ribonuclease K6,20053,130,1.81 [1.36-2.40],4.9897434642816814e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASET2,Ribonuclease T2,23447,169,2.19 [1.38-3.46],0.0008310822722265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO3,R-spondin-3,23465,170,2.13 [1.39-3.27],0.0005625095403625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARA5,Scavenger receptor class A member 5,23472,168,2.48 [1.63-3.77],2.0384887072885e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB2,Lysosome membrane protein 2,22603,168,2.34 [1.70-3.22],1.8318801245366066e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFRP1,Secreted frizzled-related protein 1,22980,168,1.58 [1.22-2.05],0.0005283882429613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC1,Sialoadhesin,23346,169,2.10 [1.57-2.80],4.621053487853609e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC5,Sialic acid-binding Ig-like lectin 5,23278,167,1.30 [1.12-1.51],0.0007109327714099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORCS2,VPS10 domain-containing receptor SorCS2,22716,165,2.05 [1.47-2.87],2.705539201904873e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK1,Serine protease inhibitor Kazal-type 1,23278,167,1.71 [1.28-2.27],0.000223829023474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT1,Kunitz-type protease inhibitor 1,23190,167,2.16 [1.39-3.36],0.0006084507975147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON1,Spondin-1,23263,169,1.88 [1.34-2.66],0.0003113565631735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON2,Spondin-2,23156,170,2.57 [1.79-3.68],2.8890564872911664e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",23559,171,1.83 [1.30-2.58],0.0005044379010136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAFA5,Chemokine-like protein TAFA-5,23153,167,1.96 [1.42-2.71],4.201811525466447e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCN2,Transcobalamin-2,23524,171,1.95 [1.34-2.85],0.0005414584683443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF3,Trefoil factor 3,23259,170,1.67 [1.35-2.06],2.396063065309094e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFA,Protransforming growth factor alpha,23240,169,1.69 [1.31-2.18],5.478713016969592e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP4,Metalloproteinase inhibitor 4,23278,167,1.70 [1.25-2.31],0.0006871113326633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS5,Transmembrane protease serine 5,22949,167,1.87 [1.32-2.66],0.0004723427812654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,23062,169,1.92 [1.42-2.60],2.2772986895911348e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,23062,169,1.36 [1.16-1.60],0.0002044554214013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,23536,169,2.00 [1.50-2.68],3.002993425937958e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,23327,169,2.00 [1.45-2.76],2.819694739190365e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,23263,169,1.83 [1.42-2.35],2.940375987921701e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,23263,169,2.31 [1.60-3.33],8.057694648738202e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,23465,170,2.09 [1.52-2.88],6.503027616670147e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,23278,167,2.73 [1.92-3.88],2.283974369562565e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,23278,167,1.78 [1.46-2.17],1.2086271490466783e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,23498,168,2.02 [1.49-2.73],5.698678206185693e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,23062,169,1.62 [1.34-1.96],8.282814695706891e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,23062,169,1.73 [1.38-2.15],1.4940161761081007e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13,Tumor necrosis factor ligand superfamily member 13,23346,169,2.53 [1.60-4.01],7.505586389539338e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23524,171,2.21 [1.46-3.34],0.0001604491474882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREML2,Trem-like transcript 2 protein,23278,167,1.85 [1.29-2.64],0.0007556564012281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ULBP2,UL16-binding protein 2,23062,169,1.84 [1.34-2.52],0.0001414259322579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAM1,Vascular cell adhesion protein 1,23341,171,2.18 [1.39-3.41],0.0006924777096373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG4,V-set and immunoglobulin domain-containing protein 4,23248,167,2.93 [2.26-3.82],9.91802248892269e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2,Brorin,22988,168,2.16 [1.57-2.97],2.3314857850810484e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC2,WAP four-disulfide core domain protein 2,22096,160,2.08 [1.60-2.70],3.188639739652933e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WNT9A,Protein Wnt-9a,22853,166,2.39 [1.68-3.42],1.5919743109260191e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XCL1,Lymphotactin,23465,170,1.46 [1.20-1.78],0.0002091638240954
